Loading...
ROCO
4138
Market cap67mUSD
Oct 08, Last price  
53.80TWD
1D
0.00%
1Q
5.70%
Jan 2017
21.69%
IPO
12.25%
Name

Dynamic Medical Technologies Inc

Chart & performance

D1W1MN
ROCO:4138 chart
P/E
14.13
P/S
1.55
EPS
3.81
Div yield, %
7.01%
Shrs. gr., 5y
7.30%
Rev. gr., 5y
6.56%
Revenues
1.39b
-11.82%
1,214,814,0001,156,622,0001,164,815,0001,178,195,0001,009,308,0001,028,183,0001,291,692,0001,593,502,0001,572,704,0001,386,760,000
Net income
152m
-25.97%
118,454,000113,078,000104,975,000112,521,000115,995,000123,206,000137,111,000210,319,000205,393,000152,059,000
CFO
310m
+38.19%
250,354,000145,183,000147,464,000274,476,000248,551,000277,645,000276,929,000360,946,000224,113,000309,704,000
Dividend
Apr 23, 20264.2 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Dynamic Medical Technologies Inc., encompassing its various subsidiaries, operates within the aesthetic industry throughout Taiwan and Hong Kong. The company's primary focus involves the commercialization and upkeep of cosmetic laser and light-based equipment. Its extensive product range, which it both distributes and sells, includes specialized aesthetic medical instruments, body sculpting technologies, injectable dermal fillers, and high-grade cosmeceuticals, alongside a diverse selection of beauty treatment and cosmetic items. Additionally, Dynamic Medical Technologies delivers professional services such as training for aestheticians and consultation for clinical operational efficiency. The company is organized into distinct segments: Dynamic, Hong Kong Dynamic, Excelsior Beauty, and CYJ. Established in 1992, its main operational hub is situated in New Taipei City, Taiwan.

Key people

Chairman of the Board · since 2011
Kuan-Liang Chen
Chief Financial Officer · since 2025
Po-Yuan Chen
General Manager · since 2025
Chih-Hao Chiang
General Manager, Corporate Governance Officer · since 2025
Director · since 2020
Director · since 2019
Kuo-Lon Wu
Director · since 2025
Director · since 2020
Director · since 2024
Independent Director · since 2021
Fengzhi Lin
Independent Director · since 2024
Cuizhen Zeng
Independent Director · since 2024
IPO date
Dec 28, 2009
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT